The Promise and Peril of Fast-Tracking the Coronavirus Vaccine | WSJ

The Promise and Peril of Fast Tracking Coronavirus Vaccine Development | WSJПодробнее

How Omicron Challenges U.S. and China on Vaccine Diplomacy | WSJПодробнее

Breakthrough Covid-19 Cases Raise Questions About Immunity | WSJПодробнее

What China and Russia Hope to Gain From Sharing Their Covid Vaccines | WSJПодробнее

How to Make Sense of Coronavirus Data | WSJПодробнее

New Covid Variant Symptoms…Подробнее

Three Tech Tips for Booking a Covid-19 Vaccine Appointment | WSJПодробнее

The Logistics Behind the U.S. Covid Vaccine Rollout | WSJПодробнее

Vaccine Efficacy Numbers, Explained | WSJПодробнее

Are Covid-19 Vaccine Incentives Paying Off? | WSJПодробнее

How Coronavirus Became a Global Pandemic | WSJПодробнее

How Covid’s Delta Variant Quickly Spread Globally | WSJПодробнее

The Science Behind How the Body Clears Coronavirus | WSJПодробнее

Global failure to share vaccines equitably is fuelling a two-track COVID-19 pandemicПодробнее

What It Would Take to Reach Herd Immunity | WSJПодробнее

The Debate Over Whether Colleges Can Require Covid-19 Vaccines | WSJПодробнее

How Coronavirus Spread Across the U.S. | WSJПодробнее

How Scientists Are Trying to Develop a Coronavirus Vaccine | WSJПодробнее

Why the Omicron Variant Is Concerning Scientists | WSJПодробнее

'Not such a good idea' to fast-track a coronavirus vaccine, says infectious diseases expertПодробнее